AstraZeneca gets complete response letter for three-drug COPD inhaler
The FDA turned down the British drugmaker's approval application for PT010, which won approval in Japan a few months ago and is marketed there as Breztri Aerosphere. GlaxoSmithKline won approval for a three-drug COPD inhaler, Trelegy Ellipta, in 2017.